
Zenotech Laboratories Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals
2026-05-19 08:39:20Zenotech Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The downgrade reflects deteriorating fundamentals, weak quarterly results, and increasingly bearish technical signals, signalling caution for investors in this micro-cap pharmaceutical stock.
Read MoreAre Zenotech Laboratories Ltd latest results good or bad?
2026-04-30 19:16:27Zenotech Laboratories Ltd's latest financial results for Q4 FY26 reflect significant operational challenges. The company reported net sales of ₹8.87 crores, which represents a notable decline of 25.02% compared to the previous quarter and a year-on-year decrease of 20.16%. This marks the lowest quarterly revenue in the past seven quarters, indicating potential issues with market demand or competitive positioning. The net profit for the quarter was ₹-3.15 crores, a dramatic shift from a profit of ₹1.93 crores in the prior quarter, highlighting a substantial deterioration in profitability. The operating margin fell sharply to 2.03%, down from 36.09% in the previous quarter, indicating severe operational stress and inefficiencies. Additionally, the profit after tax (PAT) margin turned negative at -35.51%, contrasting with a positive margin of 16.31% just one quarter earlier. The financial performance suggest...
Read More
Zenotech Laboratories Ltd Reports Sharp Decline in Quarterly Financial Performance Amid Sector Challenges
2026-04-30 08:00:09Zenotech Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a significant downturn in its financial performance for the quarter ended March 2026. The company’s key metrics, including net sales, profit after tax, and operating margins, have all deteriorated sharply compared to its recent historical averages, signalling a shift from positive to negative financial trends.
Read More
Zenotech Laboratories Ltd is Rated Sell
2026-04-26 10:10:02Zenotech Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read MoreWhen is the next results date for Zenotech Laboratories Ltd?
2026-04-24 23:15:59The next results date for Zenotech Laboratories Ltd is scheduled for April 29, 2026....
Read More
Zenotech Laboratories Ltd is Rated Sell
2026-04-15 10:10:03Zenotech Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read MoreCompliances-Reg.24(A)-Annual Secretarial Compliance
27-May-2026 | Source : BSESubmission of Annual Secretarial Compliance Report for the financial year 2025-26
Announcement under Regulation 30 (LODR)-Newspaper Publication
30-Apr-2026 | Source : BSECopies of extract of Audited Standalone Financial Results of the Company for the quarter and financial year ended March 31 2026 as published in todays newspaper i.e. April 30 2026.
Board Meeting Outcome for Outcome Of The Board Meeting Held On April 29 2026
29-Apr-2026 | Source : BSESubmission of Audited Standalone Financial Results for the quarter and financial year ended March 31 2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Zenotech Laboratories Ltd has announced 17:22 rights issue, ex-date: 01 Jun 17
